Creativity in exploration, off the beaten track, and curiosity to discover from a wide variety of angles.
The de Duve Institute is a multidisciplinary biomedical research institute housing several research laboratories of the Faculty of Medicine of the Catholic University of Louvain (UCLouvain), as well as the laboratories of the Ludwig Institute for Cancer Research.
3 key principles are essential to us:
That's our mission.
By developing a deeper understanding of diseases and identifying their causes, we can improve treatment, prevent illness and promote recovery.
By studying the physiology of the disease and understanding how it interacts with the body, healthcare professionals can develop more precise and targeted treatments.
Creativity in exploration, off the beaten track, and curiosity to discover from a wide variety of angles.
Excellence through top-level research, mastery of the research professions, ambition and rigor.
Impact of the Institute's discoveries, which are real starting points for future solutions to various diseases.
In 1974, Christian de Duve was awarded the Nobel Prize for Physiology or Medicine. That year, he founded the international Institute of Molecular and Cellular Pathology (ICP), later renamed the de Duve Institute.
Christian de Duve graduated in medicine from the Catholic University of Louvain (UCL) in 1941 and in chemistry from UCL in 1946. He simultaneously pursued a career as a teacher and researcher at UCL and at the Rockefeller University in New York (USA) ...
Since Christian de Duve was awarded the Nobel Prize for Medicine, many of the Institute's researchers have been striving to reveal the fundamental processes of life and contribute to our mission : Advancing knowledge, transforming health care.
Their work have been published in the most prestigious international journals and the quality of their discoveries is recognised by the scientific community.
Thanks to their talent and the excellence of their research, many researchers have won coveted awards.
Our researchers, working in 31 laboratories and 5 research programs, are studying more than 100 diseases.
Each year, they share the results of their work and promote collaboration between laboratories as well as optimal use of the Institute's resources.
Our researchers' progress and discoveries are summarised in an annual scientific report.
The de Duve Institute is made up of two structural entities: an international non-profit association called de Duve Institute aisbl (abbreviated to DDI) and a UCLouvain institute (abbreviated to DDUV).
The two entities are managed in close collaboration by a Coordination Committee made up of four scientists from the Institute. A four-member International Scientific Council oversees the quality of research and recruitment. The DDI is also managed by a Board of Directors including representatives from the Université Catholique de Louvain (UCLouvain).
The urgent need to tackle antibiotic resistance
Antibiotic resistance is a natural phenomenon that occurs when bacteria become resistant to antibiotics. According to the WHO, multi-resistant infections are one of the world's major threats to public health.
By 2050, 10 million deaths will be directly attributed to antibiotic resistance each year if no action is taken. Simple surgical procedures could be called into question, even in healthy individuals, because of the microbiological risk.
Humus, a citizen's response to antibiotic resistance
A team of 4 researchers from the de Duve Institute is launching the Humus project. Under the guidance of Professor Jean-François Collet, Chloé Petre is in charge of setting up this citizen science project, largely inspired by the Australian project Soils for Science.
Soil microbial biodiversity is largely unexploited. Only a small percentage of this microbiological treasure trove is known to date. The aim of our 4 researchers is to collect 10,000 soil samples, thanks to the voluntary commitment of the general public, in order to search for the potential antibiotics of tomorrow.
They are also keen to make the Belgian public aware of the urgency of antibiotic resistance, but also of the hopes that scientific research holds.
How about helping us to identify tomorrow's antibiotics?
To get this project off the ground effectively, we need to raise €215,000 by 2025 and find corporate partners to provide funding, logistics and/or visibility.
Support the HUMUS project:
o For €150, you donate 50 soil sample collection kits
o For €1,250, you will finance 200 Petri dishes and consumables for cultivating soil microbes
o For €7,500, you will help promote the project to the public for 3 months.